Edesa Biotech, Inc.
EDSA
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for inflammatory and immune-related diseases. Edesa Biotech’s current pipeline centers on host-directed and targeted therapies designed for medical dermatology and respiratory conditions, including investigational programs for acute respiratory distress syndrome, chronic allergic contact dermatitis, vitiligo, systemic sclerosis, and pulmonary fibrosis. The company’s work includes monoclonal antibody and topical treatment candidates intended to modulate immune pathways and address conditions with significant unmet medical needs. Edesa Biotech operates as a research and development organization, advancing its product candidates through clinical studies and related regulatory activities. Headquartered in Markham, Ontario, Canada, the company plays a specialized role in the biotechnology sector by focusing on diseases driven by dysregulated inflammatory and immune responses.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$14M
▼ -16.5% YoY
Op. Margin
–
ROIC
-77.92%
▲ +31.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$9M
▼ -49.7% YoY
Op. Cash Flow (TTM)
-$9M
▼ -49.7% YoY
Net Debt
-$11M
Net Cash Position
Cash & Equiv.
$11M
Continue Research
Peers
Biotechnology · Pick stocks to compare with EDSA
Edesa Biotech (EDSA) in three numbers
Questions about Edesa Biotech
Is Edesa Biotech a high-quality business?
Edesa Biotech scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from company filings. Its best check is net debt at -$11M, and its weakest is return on capital at -77.9%. The Quality tab shows every check against its target.
Does Edesa Biotech (EDSA) pay a dividend?
No. Edesa Biotech (EDSA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: company filings. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing EDSA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.